Boothbay Fund Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,797
Closed -$123K 2429
2025
Q4
$123K Buy
+11,797
New +$118K ﹤0.01% 1722
2023
Q2
Sell
-16,108
Closed -$269K 2232
2023
Q1
$269K Sell
16,108
-14,344
-47% -$203K 0.01% 1579
2022
Q4
$386K Buy
30,452
+5,505
+22% +$67K 0.01% 1276
2022
Q3
$299K Buy
24,947
+1,494
+6% +$20.5K 0.01% 1538
2022
Q2
$330K Sell
23,453
-24,974
-52% -$329K 0.01% 1411
2022
Q1
$600K Buy
48,427
+6,176
+15% +$74.1K 0.01% 1192
2021
Q4
$475K Sell
42,251
-10,909
-21% -$131K 0.01% 1037
2021
Q3
$674K Buy
+53,160
New +$732K 0.02% 947

Other funds holding RXST

Boothbay Fund Management's RXST Position: Q1 2026 in Review

Boothbay Fund Management sold out of RxSight (RXST) in Q1 2026, closing a stake of 11,797 shares — an estimated $123K sold.

Boothbay Fund Management first reported a position in RXST in Q3 2021 and held it in 8 quarters. The position peaked at $674K in Q3 2021. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Boothbay Fund Management reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 11,797 RxSight shares in Q1 2026, an estimated $123K.
  • Boothbay Fund Management first reported a position in RxSight in Q3 2021 and held it in 8 quarters.
  • Boothbay Fund Management's RxSight position peaked at $674K in Q3 2021.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.